Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO
| Image |  |
|---|---|
| Description | scientific article published on 20 April 2018 |
| Author/s |
author: Vittorina Zagonel |
| Publication date | April 20, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |